Buscador de publicaciones

La producción científica de nuestros investigadores es muy elevada. En 2022 se publicaron 1.629 artículos en revistas científicas con un factor de impacto global que superó los 15.000 puntos.

Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach.

PMID: 35822847
Revista: Future cardiology
Año: 2022
Referencia: Future Cardiol. 2022 Jul 13. doi: 10.2217/fca-2022-0044.
Factor de impacto: 0
Tipo de publicación: Revisión en revista internacional
Autores: Barrios, Vivencio, Cinza-Sanjurjo, Sergio, Garcia-Alegria, Javier, Freixa-Pamias, Roman, Llordachs-Marques, Frederic, Molina, Carlos A, Santamaria, Amparo, Suarez Fernandez, Carmen, Vivas, David et al.
DOI: 10.2217/fca-2022-0044

Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach.

PMID: 35822847
Revista: Future cardiology
Año: 2022
Referencia: Future Cardiol. 2022 Sep;18(9):743-754. doi: 10.2217/fca-2022-0044. Epub 2022 Jul 13.
Factor de impacto:
Tipo de publicación: Revisión en revista internacional
Autores: Barrios, Vivencio; Cinza-Sanjurjo, Sergio; Freixa-Pamias, Roman; Garcia-Alegria, Javier; Llordachs-Marques, Frederic; Molina, Carlos A; Santamaria, Amparo; Suarez Fernandez, Carmen; Vivas, David et al.
DOI: 10.2217/fca-2022-0044

Routine Gadolinium Use for MRI Follow-up of Multiple Sclerosis: Counterpoint-Gadolinium Should Not Always Be Used to Assess Disease Activity.

PMID: 34786958
Revista: AMERICAN JOURNAL OF ROENTGENOLOGY
Año: 2022
Referencia: AJR Am J Roentgenol. 2022 Jul;219(1):26-27. doi: 10.2214/AJR.21.27069. Epub 2021 Nov 17.
Factor de impacto: 3.959
Tipo de publicación: Carta con FI
Autores: Rovira, Alex, Auger, Cristina et al.
DOI: 10.2214/AJR.21.27069

Routine Gadolinium Use for MRI Follow-up of Multiple Sclerosis: Counterpoint-Gadolinium Should Not Always Be Used to Assess Disease Activity.

PMID: 34786958
Revista: AMERICAN JOURNAL OF ROENTGENOLOGY
Año: 2022
Referencia: AJR Am J Roentgenol. 2022 Jul;219(1):26-27. doi: 10.2214/AJR.21.27069. Epub 2021 Nov 17.
Factor de impacto:
Tipo de publicación: Carta con FI
Autores: Auger, Cristina; Rovira, Alex et al.
DOI: 10.2214/AJR.21.27069

RRM1 variants cause a mitochondrial DNA maintenance disorder via impaired de novo nucleotide synthesis.

PMID: 35617047
Revista: JOURNAL OF CLINICAL INVESTIGATION
Año: 2022
Referencia: J Clin Invest. 2022 Jul 1;132(13). pii: 145660. doi: 10.1172/JCI145660.
Factor de impacto: 14.808
Tipo de publicación: Artículo en revista internacional
Autores: Smeets, H J M, Gorman, Grainne S, Bonnen, Penelope E, Taylor, Robert W, Hirano, Michio, Chinnery, Patrick F, Rodenburg, Richard J, Tanji, Kurenai, Shintaku, Jonathan, Pernice, Wolfgang M et al.
DOI: 10.1172/JCI145660

RRM1 variants cause a mitochondrial DNA maintenance disorder via impaired de novo nucleotide synthesis.

PMID: 35617047
Revista: JOURNAL OF CLINICAL INVESTIGATION
Año: 2022
Referencia: J Clin Invest. 2022 Jul 1;132(13). pii: 145660. doi: 10.1172/JCI145660.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Blakely, Emma L; Bonnen, Penelope E; Brown, Zuben P; Chinnery, Patrick F; Donaldson, Alan; Eyaid, Wafaa; Frank, Joachim; Gc, Jeevan B; Gorman, Grainne S; Hellebrekers, Debby Mei et al.
DOI: 10.1172/JCI145660

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial.

PMID: 35298906
Revista: LANCET ONCOLOGY
Año: 2022
Referencia: Lancet Oncol. 2022 Apr;23(4):465-478. doi: 10.1016/S1470-2045(22)00122-X. Epub 2022 Mar 14.
Factor de impacto: 41.316
Tipo de publicación: Artículo en revista internacional
Autores: de Melo, Andreia Cristina, Shparyk, Yaroslav, Rakhmatullina, Irina, Bondarenko, Igor, Colombo, Nicoletta, Svintsitskiy, Valentyn, Biela, Luciano, Nechaeva, Marina, Lorusso, Domenica, Scambia, Giovanni et al.
DOI: 10.1016/S1470-2045(22)00122-X

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial.

PMID: 35298906
Revista: LANCET ONCOLOGY
Año: 2022
Referencia: Lancet Oncol. 2022 Apr;23(4):465-478. doi: 10.1016/S1470-2045(22)00122-X. Epub 2022 Mar 14.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Biela, Luciano; Bondarenko, Igor; Cibula, David; Colombo, Nicoletta; de Melo, Andreia Cristina; Dvorkin, Mikhail; Fedenko, Alexander; Goble, Sandra; Kristeleit, Rebecca; Lin, Kevin K et al.
DOI: 10.1016/S1470-2045(22)00122-X

Rumination syndrome, critical review.

PMID: 34023479
Revista: Gastroenterologia y Hepatologia
Año: 2022
Referencia: Gastroenterol Hepatol. 2022 Feb;45(2):155-163. doi: 10.1016/j.gastrohep.2021.03.013. Epub 2021 May 21.
Factor de impacto: 2.102
Tipo de publicación: Revisión en revista nacional
Autores: Alcala-Gonzalez, L G; Serra, X; Barba, E et al.
DOI: 10.1016/j.gastrohep.2021.03.013

Rumination syndrome, critical review.

PMID: 34023479
Revista: Gastroenterologia y Hepatologia
Año: 2022
Referencia: Gastroenterol Hepatol. 2022 Feb;45(2):155-163. doi: 10.1016/j.gastrohep.2021.03.013. Epub 2021 May 21.
Factor de impacto:
Tipo de publicación: Revisión en revista nacional
Autores: Alcala-Gonzalez, L G; Barba, E; Serra, X et al.
DOI: 10.1016/j.gastrohep.2021.03.013

Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer-phase 3 ASCENT study subanalysis.

PMID: 35680967
Revista: npj Breast Cancer
Año: 2022
Referencia: NPJ Breast Cancer. 2022 Jun 9;8(1):72. doi: 10.1038/s41523-022-00439-5.
Factor de impacto: 6.923
Tipo de publicación: Artículo en revista internacional
Autores: Cortes, Javier, Carey, Lisa A, Loirat, Delphine, Punie, Kevin, Bardia, Aditya, Dieras, Veronique, Dalenc, Florence, Diamond, Jennifer R, Fontaine, Christel, Rugo, Hope S et al.
DOI: 10.1038/s41523-022-00439-5

Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer.

PMID: 36027558
Revista: JOURNAL OF CLINICAL ONCOLOGY
Año: 2022
Referencia: J Clin Oncol. 2022 Oct 10;40(29):3365-3376. doi: 10.1200/JCO.22.01002. Epub 2022 Aug 26.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Bardia, Aditya; Ciruelos, Eva; Cortes, Javier; Dalenc, Florence; Delaney, Rosemary; Fu, Olivia; Jhaveri, Komal L; Lin, Lanjia; Loirat, Delphine; Marme, Frederik et al.
DOI: 10.1200/JCO.22.01002

Safety and Acceptance of COVID-19 Vaccination After Multisystem Inflammatory Syndrome in Children (MIS-C) in Spain.

PMID: 35904132
Revista: Journal of the Pediatric Infectious Diseases Society
Año: 2022
Referencia: J Pediatric Infect Dis Soc. 2022 Oct 25;11(10):471-473. doi: 10.1093/jpids/piac076.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Aguilera-Alonso, David; Carrasco-Colom, Jaume; Epalza, Cristina; Escartin-Paredes, Paula; Fumado, Victoria; Grasa, Carlos; Hermoso-Ibanez, Concepcion; Herrero, Blanca; Leoz, Ines; Moraleda, Cinta et al.
DOI: 10.1093/jpids/piac076

Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.

PMID: 35064011
Revista: Journal for ImmunoTherapy of Cancer
Año: 2022
Referencia: J Immunother Cancer. 2022 Jan;10(1). pii: jitc-2021-003777. doi: 10.1136/jitc-2021-003777.
Factor de impacto: 13.751
Tipo de publicación: Artículo en revista internacional
Autores: Gilbert, Lucy, Tinker, Anna V, Brown, Jubilee, Mathews, Cara, Press, Joshua, Sabatier, Renaud, O'Malley, David M, Samouelian, Vanessa, Boni, Valentina, Duska, Linda et al.
DOI: 10.1136/jitc-2021-003777

Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.

PMID: 35064011
Revista: Journal for ImmunoTherapy of Cancer
Año: 2022
Referencia: J Immunother Cancer. 2022 Jan;10(1). pii: jitc-2021-003777. doi: 10.1136/jitc-2021-003777.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Boni, Valentina; Brown, Jubilee; Duan, Tao; Duska, Linda; Ghamande, Sharad; Ghatage, Prafull; Gilbert, Lucy; Guo, Wei; Han, Xinwei; Im, Ellie et al.
DOI: 10.1136/jitc-2021-003777

Safety and effectiveness of ferric carboxymaltose intravenous therapy in pediatric patients with chronic kidney disease.

PMID: 36275063
Revista: Frontiers in Pediatrics
Año: 2022
Referencia: Front Pediatr. 2022 Oct 6;10:967233. doi: 10.3389/fped.2022.967233. eCollection 2022.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Ariceta, Gema; Cruz, Alejandro; Garcia-Ortega, Patricia; Jimenez-Lozano, Ines; Lopez, Mercedes; Lopez, Mercedes; Polo, Aurora Fernandez et al.
DOI: 10.3389/fped.2022.967233

Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study).

PMID: 35171022
Revista: Microbiology Spectrum
Año: 2022
Referencia: Microbiol Spectr. 2022 Feb 23;10(1):e0178421. doi: 10.1128/spectrum.01784-21. Epub 2022 Feb 16.
Factor de impacto: 7.171
Tipo de publicación: Artículo en revista internacional
Autores: Monforte, Arnau, Los-Arcos, Ibai, Martin-Gomez, Maria Teresa, Campany-Herrero, David, Sacanell, Judith, Berastegui, Cristina, Marquez-Algaba, Ester, Sempere, Abiu, Nuvials, Xavier, Castells, Lluis et al.
DOI: 10.1128/spectrum.01784-21

Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study).

PMID: 35171022
Revista: Microbiology Spectrum
Año: 2022
Referencia: Microbiol Spectr. 2022 Feb 23;10(1):e0178421. doi: 10.1128/spectrum.01784-21. Epub 2022 Feb 16.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Berastegui, Cristina; Bravo, Carles; Campany-Herrero, David; Castells, Lluis; Deu, Maria; Gavalda, Joan; Len, Oscar; Los-Arcos, Ibai; Marquez-Algaba, Ester; Martin-Gomez, Maria Teresa et al.
DOI: 10.1128/spectrum.01784-21

Safety and Efficacy of Devices Delivering Inhaled Antibiotics among Adults with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and a Network Meta-Analysis.

PMID: 35203878
Revista: Antibiotics-Basel
Año: 2022
Referencia: Antibiotics (Basel). 2022 Feb 19;11(2). pii: antibiotics11020275. doi: 10.3390/antibiotics11020275.
Factor de impacto: 4.639
Tipo de publicación: Revisión en revista internacional
Autores: Tejada, Sofia, Forero, Carlos G, Gallego, Miguel, Soriano, Joan B, Cardinal-Fernandez, Pablo A, Ehrmann, Stephan, Rello, Jordi, Ramirez-Estrada, Sergio et al.
DOI: 10.3390/antibiotics11020275

Safety and Efficacy of Devices Delivering Inhaled Antibiotics among Adults with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and a Network Meta-Analysis.

PMID: 35203878
Revista: Antibiotics-Basel
Año: 2022
Referencia: Antibiotics (Basel). 2022 Feb 19;11(2). pii: antibiotics11020275. doi: 10.3390/antibiotics11020275.
Factor de impacto:
Tipo de publicación: Revisión en revista internacional
Autores: Cardinal-Fernandez, Pablo A; Ehrmann, Stephan; Forero, Carlos G; Gallego, Miguel; Ramirez-Estrada, Sergio; Rello, Jordi; Soriano, Joan B; Tejada, Sofia et al.
DOI: 10.3390/antibiotics11020275

Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial.

PMID: 35716692
Revista: LANCET NEUROLOGY
Año: 2022
Referencia: Lancet Neurol. 2022 Jul;21(7):597-607. doi: 10.1016/S1474-4422(22)00185-5.
Factor de impacto: 44.182
Tipo de publicación: Artículo en revista internacional
Autores: Lanteri-Minet, Michel; Pozo-Rosich, Patricia; Ettrup, Anders; Christoffersen, Cecilie Laurberg; Josiassen, Mette Krog; Phul, Ravinder; Sperling, Bjorn; Ashina, Messoud et al.
DOI: 10.1016/S1474-4422(22)00185-5

Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial.

PMID: 35716692
Revista: LANCET NEUROLOGY
Año: 2022
Referencia: Lancet Neurol. 2022 Jul;21(7):597-607. doi: 10.1016/S1474-4422(22)00185-5.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Ashina, Messoud; Christoffersen, Cecilie Laurberg; Ettrup, Anders; Josiassen, Mette Krog; Lanteri-Minet, Michel; Phul, Ravinder; Pozo-Rosich, Patricia; Sperling, Bjorn et al.
DOI: 10.1016/S1474-4422(22)00185-5

Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial.

PMID: 34942136
Revista: LANCET NEUROLOGY
Año: 2022
Referencia: Lancet Neurol. 2022 Jan;21(1):42-52. doi: 10.1016/S1474-4422(21)00367-7.
Factor de impacto: 44.182
Tipo de publicación: Artículo en revista internacional
Autores: Goemans, Nathalie; Mercuri, Eugenio; Deconinck, Nicolas; Mazzone, Elena S; Nascimento, Andres; Oskoui, Maryam; Saito, Kayoko; Vuillerot, Carole; Baranello, Giovanni; Boespflug-Tanguy, Odile et al.
DOI: 10.1016/S1474-4422(21)00367-7

Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial.

PMID: 34942136
Revista: LANCET NEUROLOGY
Año: 2022
Referencia: Lancet Neurol. 2022 Jan;21(1):42-52. doi: 10.1016/S1474-4422(21)00367-7.
Factor de impacto:
Tipo de publicación: Artículo en revista internacional
Autores: Abbati, Francesca; Akiyama, Kiyomu; Alemdaroglu, Ipek; Almeida Pereira, Jaqueline; Amorelli, Giulia Maria; Arnoldi, Maria Teresa; Arpin, Stephanie; Ayse Karaduman, Aynur; Balikova, Irina; Balikova, Irina et al.
DOI: 10.1016/S1474-4422(21)00367-7

Publicaciones

Buscador de publicaciones

Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach.

Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach.

Routine Gadolinium Use for MRI Follow-up of Multiple Sclerosis: Counterpoint-Gadolinium Should Not Always Be Used to Assess Disease Activity.

Routine Gadolinium Use for MRI Follow-up of Multiple Sclerosis: Counterpoint-Gadolinium Should Not Always Be Used to Assess Disease Activity.

RRM1 variants cause a mitochondrial DNA maintenance disorder via impaired de novo nucleotide synthesis.

RRM1 variants cause a mitochondrial DNA maintenance disorder via impaired de novo nucleotide synthesis.

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial.

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial.

Rumination syndrome, critical review.

Rumination syndrome, critical review.

Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer-phase 3 ASCENT study subanalysis.

Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer.

Safety and Acceptance of COVID-19 Vaccination After Multisystem Inflammatory Syndrome in Children (MIS-C) in Spain.

Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.

Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.

Safety and effectiveness of ferric carboxymaltose intravenous therapy in pediatric patients with chronic kidney disease.

Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study).

Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study).

Safety and Efficacy of Devices Delivering Inhaled Antibiotics among Adults with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and a Network Meta-Analysis.

Safety and Efficacy of Devices Delivering Inhaled Antibiotics among Adults with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and a Network Meta-Analysis.

Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial.

Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial.

Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial.

Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial.

Patronato:

Colabora:

Acreditaciones: